Alkermes plc Stock (ALKS) - Quote Nasdaq- MarketScreener

Nov 8, 2024 · Earnings Flash (ALKS) ALKERMES Posts Q3 Revenue $378.1M. Oct. 24. MT. Earnings Flash (ALKS) ALKERMES Reports Q3 EPS $0.72. Oct. 24. MT. Alkermes plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024. Oct. 24.

CouponFollow Extension

$378
OFF

Alkermes Plc Stock (ALKS) - Quote Nasdaq- MarketScreener

1 week from now

marketscreener.com

42%
OFF

Alkermes Plc (ALKS) Stock Price, News, Quote & History - Yahoo …

1 week from now

0.0900. +18.42%. Find the latest Alkermes plc (ALKS) stock quote, history, news and other vital information to help you with your stock trading and investing.

yahoo.com

43%
OFF

ALKS Stock Price | Alkermes PLC Stock Quote (U.S.: Nasdaq)

1 week from now

Nov 7, 2024 · 0.43%. $20.16B. ALKS | Complete Alkermes PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

marketwatch.com

$31
OFF

Alkermes Price Target Raised To $31 From $28 At BofA - Nasdaq

1 week from now

2 days ago · BofA raised the firm’s price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple given the recent move in biotech peer …

nasdaq.com

38%
OFF

ALKS - Alkermes Plc Stock Price - Barchart.com

1 week from now

Alkermes: Q4 Earnings Snapshot. ALKS : 28.86 (-0.38%) 3 Top Growth Stocks to Buy for December 2023 Barchart - Fri Dec 1, 2023. Here are three of the best growth stocks to buy …

barchart.com

70%
OFF

Alkermes Plc: Fundamental Analysis And Financial Ratings | ALKS ...

1 week from now

Summary: Alkermes plc. The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility. From a short-term investment …

marketscreener.com

$40.00
OFF

Mizuho Boosts Alkermes (NASDAQ:ALKS) Price Target To $40.00

1 week from now

1 day ago · Shares of NASDAQ ALKS opened at $28.35 on Wednesday. The company has a market capitalization of $4.59 billion, a P/E ratio of 14.91, a P/E/G ratio of 0.98 and a beta of …

defenseworld.net

$0.11
OFF

Alkermes Plc (NASDAQ:ALKS) Shares Sold By Principal

1 week from now

3 days ago · Shares of Alkermes stock traded down $0.11 on Wednesday, reaching $29.12. 350,567 shares of the stock were exchanged, compared to its average volume of 1,829,356. …

marketbeat.com

FAQs about Alkermes plc Stock (ALKS) - Quote Nasdaq- MarketScreener Coupon?

Does NASDAQ use Alkermes plc ordinary shares (AlkS) value to determine compliance?

NASDAQ does not use this value to determine compliance with the listing requirements. Alkermes plc Ordinary Shares (ALKS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ...

Is Alkermes a Novo Nordisk company?

DUBLIN , May 2, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. In conne... ...

Where is Alkermes plc headquartered?

Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. Trailing total returns as of 11/11/2024, which may include dividends or other distributions. Benchmark is ...

What time does Alkermes hold a conference call & webcast?

DUBLIN , Oct. 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. DUBLIN , Sept. 25, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that it will host an investor event for financial analysts and institutional investors on Wednesday, Oct. 9, 2024 st... ...

What does Alkermes do?

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. ...

Did health Alkermes report more revenue than expected?

Health Alkermes Reported More Revenue Than Expected. Here’s Why the Stock Is Falling. Shares of Alkermes were down 2.74% after the Food and Drug Administration published a warning letter alleging Vivitrol ads didn't include important risk information. If Vivitrol, which is used to prevent relapses in opioi... ...